  | Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (02 February 2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Poster presentation]. Belgian Week of Gastroenterology 2024, Antwerp, Belgium.  Peer reviewed |
| MONIN, L., Reenaers, C., Grandfils, S., Latour, P., Van Kemseke, C., KROPP, S., Louis, E., & VIEUJEAN, S. (2024). Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric study [Poster presentation]. Belgian Week of Gastroenterology 2024. Peer reviewed |
| Holvoet, T., Brusselle, E., Verstockt, B., Lenfant, M., Julsgaard, M., Drobne, D., Thakor, A., Gordon, H., Molnar, T., Savarino, E., Ribaldone, D. G., Miheller, P., VIEUJEAN, S., Candel, I., Viso, M., Bettenworth, D., Eden, P., Issachar, A., & Lobaton, T. (2024). Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series [Poster presentation]. Belgian Week of Gastroenterology 2024, Antwerp, Belgium. Peer reviewed |
 | MONIN, L., Reenaers, C., Grandfils, S., Latour, P., Van Kemseke, C., KROPP, S., Louis, E., & VIEUJEAN, S. (2024). Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric study [Poster presentation]. European Crohn's and Colitis Organisation 2024. Peer reviewed |
Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Paper presentation]. Belgian Week of Gastroenterology 2024. Peer reviewed |
 | Dragoni, G., Innocenti, T., Amiot, A., Castiglione, F., Melotti, L., Festa, S., Savarino, E., Truyens, M., Argyriou, K., Noviello, D., Molnar, T., Bouillon, V., Bezzio, C., Eder, P., Fernandes, S., Kagramanova, A., Armuzzi, A., Oliveira, R., Viola, A., ... TOFA-poSTOP Study Group. (2024). Pre-operative exposure to tofacitinib is as safe as biologics in patients with ulcerative colitis undergoing colectomy: a multicentre observational study [Poster presentation]. European Crohn's and Colitis Organisation 2024. Peer reviewed |
 | Holvoet, T., Verstockt, B., Lenfant, M., Julsgaard, M., Drobne, D., Thakor, A., Gordon, H., Molnar, T., Savarino, E., Ribaldone, D. G., Miheller, P., VIEUJEAN, S., Candel, I., Menchen, V., Bettenworth, D., Eder, P., Issachar, A., & Lobaton, T. (2024). Safety and effectiveness of vedolizumab and ustekinumab in inflammatory bowel disease patients after liver transplantation for primary sclerosing cholangitis: results from an ECCO-confer case series [Poster presentation]. European Crohn's and Colitis Organisation 2024. Peer reviewed |
| Stepniak, M., Adam, P., Salée, C., Loly, J.-P., VIEUJEAN, S., Reenaers, C., Fonzé, F., Massot, C., COIMBRA MARQUES, C., DECKER, E., BLETARD, N., Delvenne, P., Speca, S., Louis, E., & Meuwis, M.-A. (2024). Study of the role of the epithelium in the initiation and progression of intestinal fibrosis in Ulcerative Colitis [Paper presentation]. Belgian Week of Gastroenterology 2024. Peer reviewed |
| Adam, P., Salée, C., Stepniak, M., Loly, J.-P., VIEUJEAN, S., KROPP, S., Reenaers, C., Fonzé, F., Massot, C., BLETARD, N., COIMBRA MARQUES, C., DECKER, E., Delvenne, P., Louis, E., & Meuwis, M.-A. (2024). Characterization of the impact of NKCC1 in colorectal carcinogenesis [Paper presentation]. Belgian Week of Gastroenterology 2024. Peer reviewed |
| VIEUJEAN, S., Desseaux, K., Laharie, D., Satsangi, J., Ding, N., Siegmund, B., D’Haens, G., Picon, L., Bossuyt, P., Vuitton, L., Irving, P., Viennot, S., Lamb, C., Pollok, R., Baert, F., Nachury, M., Fumery, M., Gilletta, C., Resche-Rigon, M., ... GETAID and the SPARE-Biocycle research group. (2024). No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combination therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE [Poster presentation]. Belgian Week of Gastroenterology 2024. Peer reviewed |
| VIEUJEAN, S., Desseaux, K., Laharie, D., Satsangi, J., Ding, N., Siegmund, B., D’Haens, G., Picon, L., Bossuyt, P., Vuitton, L., Irving, P., Viennot, S., Lamb, C., Pollok, R., Baert, F., Nachury, M., Fumery, M., Gilletta, C., Resche-Rigon, M., ... GETAID and the SPARE-Biocycle research group. (2024). No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combo therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE [Poster presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. Peer reviewed |
 | Verstockt, B., Taelman, T., Vavricka, S., Zabana, Y., Lenfant, M., Macaigne, G., Maillard, M., Savarino, E., Teich, N., Kiudelis, V., de la Revilla Negro, J., Ribaldone, D. G., Barreiro-de Acosta, M., Wildt, S., Rivière, P., Fumery, M., Truyens, M., Amiot, A., Marsal, J., ... Julsgaard, M. (2024). Promising efficacy of biologicals and small molecules for microscopic colitis: results from a large real-life multicenter cohort [Paper presentation]. European Crohn's and Colitis Organisation 2024. Peer reviewed |
 | Reves, J., Roager Madsen, G., Burisch, J., Wong, C., Arebi, N., Bonnet-Dodel, M., Buisson, A., Gatt, K., Ellul, P., VIEUJEAN, S., Ordas, I., Duricova, D., Rodríguez-Lago, I., Sebastian, S., Mocanu, I., Kaimakliotis, I., Goldis, A., Hernandez, V., Nachury, M., ... CROCO Study Group. (2024). Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´s Disease Cohort) study [Poster presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. Peer reviewed |
 | Testa, G., Ribaldone, D. G., Verstockt, B., Molnar, T., Savarino, E., Schmidt, C., VIEUJEAN, S., Teich, N., Meianu, C., Juillerat, P., Grellier, N., & Lobaton, T. (2024). JAK inhibitors and S1P receptor modulators for the treatment of antibiotic refractory chronic pouchitis: an ECCO CONFER Multicentre Case Series [Poster presentation]. European Crohn's and Colitis Organisation 2024. Peer reviewed |
| Torres, J., Roager Madsen, G., Burisch, J., Wong, C., Arebi, N., Bonnet-Dodel, M., Buisson, A., Gatt, K., Ellul, P., VIEUJEAN, S., Ordas, I., Duricova, D., Rodríguez-Lago, I., Sebastian, S., Mocanu, I., Kaimakliotis, I., Goldis, A., Hernandez, V., Nachury, M., ... Torres, J. (2024). Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´s Disease [Paper presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. Peer reviewed |
| Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Poster presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden. Peer reviewed |
| Ribaldone, D. G., Vieujean, S., Mette, J., Armandi, A., Zingone, F., Savarino, E., Cañete, F., Aratari, A., Imperatore, N., Ramos, L., Plaza, R., Pugliese, D., Barberio, B., Drobne, D., & Chaparro, M. (2023). Non-hepatic solid organ transplant in patients with inflammatory bowel disease: an ECCO CONFER Multicentre Case Series. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad030 Peer Reviewed verified by ORBi |
| VIEUJEAN, S., Laharie, D., Buisson, A., Roblin, X., Fumery, M., Nancey, S., Wils, P., Altwegg, R., Seidel, L., Caron, B., & Peyrin-Biroulet, L. (2023). Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study. Digestive and Liver Disease. doi:10.1016/j.dld.2023.11.022 Peer Reviewed verified by ORBi |
 | Parigi, T. L., Vieujean, S., Paridaens, K., Dalgaard, K., Peyrin-Biroulet, L., & Danese, S. (19 November 2023). Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey. Microorganisms, 11 (11), 2806. doi:10.3390/microorganisms11112806 Peer Reviewed verified by ORBi |
 | Ribaldone, D. G., Testa, G., Verstockt, B., Molnar, T., Savarino, E., Schmidt, C., Vieujean, S., Teich, N., Meianu, C., Juillerat, P., Grellier, N., & Lobaton, T. (2023). Treatment of antibiotic refractory chronic pouchitis with JAK inhibitors and S1P receptor modulators: an ECCO CONFER Multicentre Case Series. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad194 Peer Reviewed verified by ORBi |
| Vieujean, S., Lindsay, J. O., D'Amico, F., Ahuja, V., Silverberg, M. S., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Avni Biron, I., Walsh, A., Outtier, A., Nordestgaard, R. L. M., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., ... Peyrin-Biroulet, L. (2023). Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad180 Peer Reviewed verified by ORBi |
 | Muller, M., Broséus, J., Guilloteau, A., Wasse, S., Thiéblemont, C., Nancey, S., Cadiot, G., Amiot, A., Laharie, D., Vieujean, S., Bouhnik, Y., Martineau, C., Michiels, C., Hebuterne, X., Savoye, G., Franchimont, D., Seksik, P., Beaugerie, L., Maynadié, M., ... Peyrin-Biroulet, L. (2023). Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad177 Peer Reviewed verified by ORBi |
  | Pierre, N., VIEUJEAN, S., Meuwis, M.-A., & Louis, E. (2023). Définir la rémission biologique dans la maladie de Crohn. Medi-Sphere. |
| Vieujean, S., Kotze, P. G., Netter, P., Germain, A., Louis, E., Danese, S., & Peyrin-Biroulet, L. (2023). Stemming the tide with ileocecal Crohn's disease: when is pharmacotherapy enough? Expert Opinion on Pharmacotherapy, 1 - 13. doi:10.1080/14656566.2023.2232726 Peer Reviewed verified by ORBi |
| Pierre, N., Vieujean, S., Peyrin-Biroulet, L., Meuwis, M.-A., & Louis, E. (2023). Defining biological remission in Crohn's disease: interest, challenges and future directions. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad086 Peer Reviewed verified by ORBi |
 | Vieujean, S., Lindsay, J., Rubin, D., D’Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J., Nagahori, M., Watanabe, M., Koutroubakis, I., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (06 May 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. Digestive Disease Week. Peer reviewed |
 | D’Amico, F., Vieujean, S., Caron, B., Peyrin-Biroulet, L., & Danese, S. (24 April 2023). Risk-Benefit of IBD Drugs: A Physicians and Patients Survey. Journal of Clinical Medicine, 12 (9), 3094. doi:10.3390/jcm12093094 Peer Reviewed verified by ORBi |
 | Bonsack, O., Caron, B., Baumann, C., Heba, A. C., Vieujean, S., Arnone, D., Netter, P., Danese, S., Quilliot, D., & Peyrin-Biroulet, L. (2023). Food avoidance and fasting in patients with inflammatory bowel disease: Experience from the Nancy IBD nutrition clinic. United European Gastroenterology Journal. doi:10.1002/ueg2.12385 Peer Reviewed verified by ORBi |
 | Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Louis, E., & Somja, J. (2023). In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab. Inflammatory Bowel Diseases. doi:10.1093/ibd/izad066 Peer Reviewed verified by ORBi |
| Vieujean, S., Louis, E., Danese, S., & Peyrin-Biroulet, L. (2023). A critical review of ustekinumab for the treatment of active ulcerative colitis in adults. Expert Review of Gastroenterology and Hepatology, 1 - 18. doi:10.1080/17474124.2023.2194632 Peer Reviewed verified by ORBi |
| Cremer, A., Mansour, A., Lobaton, T., Vieujean, S., Bossuyt, P., Rahier, J.-F., Baert, F., Dewit, O., Macken, E., Vijverman, A., Van Hootegem, P., Mana, F., Willandt, B., Humblet, E., D'Heygere, F., Verreth, A., El Nawar, A., Coenegrachts, J.-L., Dewit, S., ... Franchimont, D. (March 2023). Assessment of the one-year Efficacy and Safety of Tofacitinib in biologic-refractory patients with Ulcerative Colitis: a real-world Belgian cohort study [Paper presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
 | Vieujean, S., Lindsay, J., Rubin, D., D'Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (March 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
 | Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
| Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Colinet, S., Delvenne, P., Seghaye, M.-C., Louis, E., & Meuwis, M.-A. (March 2023). Characterization of Protein Disulfide Isomerases in adult and pediatric Crohn’s Disease and association with inflammation and fibrosis [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
| Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Paper presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
| Verstockt, B., Vieujean, S., Truyens, M., Julsgaard, M., Pugliese, D., Aslan, D., Prokopic, M., Lim, S., Viganò, C., Festa, S., Ramos, L., Plaza, R., Noviello, D., Savarino, E., Drobne, D., Imperatore, N., Ribaldone, D. G., Van Dongen, J., Teich, N., ... Goren, I. (March 2023). Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023, Copenhague, Denmark. Peer reviewed |
| Torres, J., Ellul, P., Vieujean, S., Ordas, I., Burisch, J., Mocanu, I., Duricova, D., Lago, I. R., Buisson, A., Goldis, A., Hernandez, V., Arebi, N., Kaimakliotis, I., Nachury, M., Fumery, M., Allocca, M., Pedersen, N., Barberio, B., Sebastian, S., ... Colombel, J.-F. (March 2023). Disability in newly diagnosed patients with Crohn´s Disease (CD): initial results from the prospective CROCO (Crohn´s Disease Cohort) Study [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. Peer reviewed |
| Ribaldone, D. G., Vieujean, S., Julsgaard, M., Savarino, E., Canete, F., Aratari, A., Imperatore, N., Ramos, L., Plaza, R., Pugliese, D., Barberio, B., Drobne, D., & Chaparro, M. (March 2023). Solid organ transplant (with the exception of liver) in patients with inflammatory bowel disease: An ECCO CONFER Multicentre Case Series [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. Peer reviewed |
 | Vieujean, S., Lindsay, J., Rubin, D., D’Amico, F., Ahuja, V., Silverberg, M., Sood, A., Yamamoto-Furusho, J. K., Nagahori, M., Watanabe, M., Koutroubakis, I. E., Foteinogiannopoulou, K., Walsh, A., Outtier, A., Abreu, M. T., Dubinsky, M., Siegel, C., Louis, E., Dotan, I., ... Peyrin-Biroulet, L. (March 2023). Analysis of Clinical Trial Screen Failures in IBD: Real World Results from the IOIBD [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. Peer reviewed |
| Verstock, B., Vieujean, S., Truyens, M., Julsgaard, M., Pugliese, D., Aslan, D., Prokopic, M., Lim, S., Vigano, C., Festa, S., Ralis, L., García, M. J., Plaza, R., Noviello, D., Savarino, E., Drobne, D., Imperatore, N., Ribaldone, D., Van Dongen, J., ... Barberio, B. (March 2023). Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy: results from a reallife multicenter cohort [Paper presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
 | Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
| D’Amico, F., Caron, B., Vieujean, S., Peyrin-Biroulet, L., & Danese, S. (March 2023). Risk-benefit assessment of IBD drugs: a physicians and patients survey [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. Peer reviewed |
 | Vieujean, S., De Vos, M., D'Amico, F., Paridaens, K., Daftary, G., Peyrin-Biroulet, L., & Danese, S. (March 2023). Inflammatory bowel disease meets fertility: a physician and patient survey [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. Peer reviewed |
| Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Colinet, S., Delvenne, P., Seghaye, M.-C., Louis, E., & Meuwis, M.-A. (March 2023). Characterization of Protein Disulfide Isomerases in adult and pediatric Crohn’s Disease and association with inflammation and fibrosis [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023, Copenhagen, Denmark. Peer reviewed |
| Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023. Peer reviewed |
 | Lovinfosse, P., Vieujean, S., Louis, E., & Hustinx, R. (2023). Commentary to "[68 Ga]Ga-FAPI-04 PET/CT on assessing Crohn's disease intestinal lesions" by Chen and colleagues. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06135-1 Peer Reviewed verified by ORBi |
| Vieujean, S., De Vos, M., D’Amico, F., Paridaens, K., Daftary, G., Dudkowiak, R., Peyrin-Biroulet, L., & Danese, S. (2023). Inflammatory bowel disease meets fertility: a physician and patient survey. Digestive and Liver Disease. doi:10.1016/j.dld.2023.01.149 Peer Reviewed verified by ORBi |
| VIEUJEAN, S., GILLARD, R., Delanaye, P., Seidel, L., Bequet, E., Salée, C., Meuwis, M.-A., Massot, C., Pierre, N., Meunier, P., Cavalier, E., & Louis, E. (2023). Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn’s disease. Scandinavian Journal of Gastroenterology, 1-8. doi:10.1080/00365521.2023.2286913 Peer Reviewed verified by ORBi |
| Vieujean, S., Moens, A., Hassid, D., Rothfuss, K., Savarino, E., Vavricka, S. R., Reenaers, C., Jacobsen, B., Allez, M., Ferrante, M., Rahier, J. F., & ECCO CONFER investigators. (2023). Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease - A case series. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjac153 Peer Reviewed verified by ORBi |
 | Vieujean, S., De Vos, M., D'Amico, F., Paridaens, K., Daftary, G., Peyrin-Biroulet, L., & Danese, S. (2023). Inflammatory bowel disease meets fertility: a physician and patient survey [Poster presentation]. Digestive Disease Week, Chicago, United States. Peer reviewed |
 | Vieujean, S., De Vos, M., D'Amico, F., Paridaens, K., Daftary, G., Peyrin-Biroulet, L., & Danese, S. (2023). Inflammatory bowel disease meets fertility: a physician and patient survey [Poster presentation]. 35th Belgian Week of Gastroenterology 2023. Peer reviewed |
| Vieujean, S., De Vos, M., Paridaens, K., Daftary, G. S., Danese, S., & Peyrin-Biroulet, L. (2023). Fertility and assisted reproductive technologies outcomes of women with non-surgically managed inflammatory bowel diseases: a systematic review. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjac170 Peer Reviewed verified by ORBi |
 | Vieujean, S., & Louis, E. (2023). Precision Medicine and Drug Optimization in Adults Inflammatory Bowel Disease Patients. Therapeutic Advances in Gastroenterology. doi:10.1177/17562848231173331 Peer Reviewed verified by ORBi |
 | Bequet, E., Salée, C., BLETARD, N., Vieujean, S., Massot, C., Fonzé, F., Sarter, H., Ley, D., Collinet, S., Seghaye, M.-C., Delvenne, P., Louis, E., & Meuwis, M.-A. (2023). Etude de la distribution de disulphides isomérases dans l’épithélium iléal et colique de maladies de Crohn sténosantes adultes et pédiatriques [Paper presentation]. Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive. Peer reviewed |
 | Chevet, E., Bassal, F., Beq, S., Bonhomme, B., Boisteau, E., Calloch, J., Cazals-Hatem, D., Delom, F., Fessart, D., Evrard, S., Hrstka, R., hupp, T., Lièvre, A., Louis, E., Mariau, J., Meuwis, M.-A., Ogier-Denis, E., Paradis, V., Pernot, S., ... Vieujean, S. (2022). AGR2 protein expression in colorectal tumour epithelial compartment [letter to the editor]. Gut, 2022-328739. doi:10.1136/gutjnl-2022-328739 Peer Reviewed verified by ORBi |
 | Vieujean, S., D'Amico, F., Netter, P., Danese, S., & Peyrin-Biroulet, L. (2022). Landscape of new drugs and targets in inflammatory bowel disease. United European Gastroenterology Journal. doi:10.1002/ueg2.12305 Peer Reviewed verified by ORBi |
 | Vieujean, S., Caron, B., Haghnejad, V., Jouzeau, J.-Y., Netter, P., Heba, A.-C., Ndiaye, N. C., Moulin, D., Barreto, G., Danese, S., & Peyrin-Biroulet, L. (09 July 2022). Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. International Journal of Molecular Sciences, 23 (14), 7611. doi:10.3390/ijms23147611 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., Caron, B., Jairath, V., Benetos, A., Danese, S., LOUIS, E., & Peyrin-Biroulet, L. (22 May 2022). Is it time to include older adults in inflammatory bowel disease trials? A call for action. The Lancet Healthy Longevity, 3 (5), 356 - e366. doi:10.1016/S2666-7568(22)00060-5 Peer reviewed |
 | Reenaers, C., Vieujean, S., COIMBRA MARQUES, C., BOUTAFFALA, L., GILLARD, R., Meunier, P., & Louis, E. (March 2022). Efficacité et sécurité du traitement par cellules souches mésenchymateuses hématopoïétiques dans les lésions ano-périnéales de maladie de Crohn : résultats d’une étude prospective monocentrique [Paper presentation]. Journées Francophones D’hépato-Gastroenterologie Et D’oncologie Digestive. Peer reviewed |
 | Reenaers, C., Vieujean, S., COIMBRA MARQUES, C., GILLARD, R., Meunier, P., BOUTAFFALA, L., & Louis, E. (March 2022). Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn's disease: results from a prospective monocentric study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022. Peer reviewed |
 | Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Somja, J., & Louis, E. (March 2022). Remission state in inflammatory bowel disease patients on anti-TNF or vedolizumab: a confocal endomicroscopy study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022. Peer reviewed |
 | VIEUJEAN, S. (2022). The potential role of the epithelial cells and the mesenchymal stem cells in Crohn's disease fibrosis : from bedside to bench and back [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/290496 |
 | Reenaers Dr, C., Vieujean, S., Coimbra, C., GILLARD, R., Meunier, P., BOUTAFFALA, L., & Louis, E. (01 January 2022). DOP31 Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn’s Disease: Results from a prospective monocentric study [Paper presentation]. 17th Congress of European Crohn's and Colitis Organisation. doi:10.1093/ecco-jcc/jjab232.070 Peer reviewed |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154 Peer Reviewed verified by ORBi |
| MOREAU, A.-C., SEIDEL, L., VIEUJEAN, S., REENAERS, C., & LOUIS, E. (January 2022). Impact clinique de la vidéocapsule endoscopique du grêle dans les saignements digestifs inexpliqués. Etude rétrospective monocentrique. Revue Médicale de Liège, 77 (1), 25-31. Editorial Reviewed verified by ORBi |
 | VIEUJEAN, S., DELANAYE, P., SEIDEL, L., CAVALIER, E., Pierre, N., & LOUIS, E. (01 January 2022). P168 Matrix Gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn’s Disease [Poster presentation]. European Crohn's and Colitis Organisation 2022. doi:10.1093/ecco-jcc/jjab232.296 Peer reviewed |
 | VIEUJEAN, S., DELANAYE, P., SEIDEL, L., CAVALIER, E., Pierre, N., & LOUIS, E. (2022). Matrix Gla Protein, a potential marker of tissue remodelling and physiological ageing of the gut in Crohn's disease [Paper presentation]. Belgian Week of Gastroenterology 2022. Peer reviewed |
 | LOLY, J.-P., VIEUJEAN, S., REENAERS, C., VAN KEMSEKE, C., SEIDEL, L., SOMJA, J., & LOUIS, E. (01 January 2022). P234 Remission state in Inflammatory Bowel Disease patients on anti TNF or vedolizumab: a confocal endomicroscopy study. Journal of Crohn's and Colitis, 16 (Supplement_1), 283-i283. doi:10.1093/ecco-jcc/jjab232.361 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., DELVENNE, P., Rieder, F., LOUIS, E., & MEUWIS, M.-A. (October 2021). Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homolog in Crohn’s Disease Fibrosis. Journal of Crohn's and Colitis, 15 (10), 1737-1750. doi:10.1093/ecco-jcc/jjab061 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (October 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. United European Gastroenterology. Peer reviewed |
| VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., DELVENNE, P., LOUIS, E., & VAN KEMSEKE, C. (2021). Unusual intra-rectal “laterally spreading tumour” in immunosuppressed patient with ulcerative colitis. Acta Gastro-Enterologica Belgica. doi:10.51821/84.3.018 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., Pariente, B., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & LOUIS, E. (July 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. 16th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2021 Virtual. Peer reviewed |
 | VIEUJEAN, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., Delvenne, P., LOUIS, E., & MEUWIS, M.-A. (July 2021). Potential Role of Epithelial Protein Disulphide Isomerases in Crohn’s Disease Fibrosis [Poster presentation]. 16th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2021 Virtual. Peer reviewed |
| Vieujean, S., Hu, S., Bequet, E., SALEE, C., MASSOT, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., COIMBRA MARQUES, C., DELVENNE, P., LOUIS, E., & MEUWIS, M.-A. (03 March 2021). Potential Role of Epithelial Protein Disulphide Isomerases in Crohn’s Disease Fibrosis [Paper presentation]. Belgian Week of Gastroenterology_33rd edition. Peer reviewed |
 | Merli, A.-M., Vieujean, S., MASSOT, C., BLETARD, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., Servais, L., Wéra, O., Oury, C., de Leval, L., Sempoux, C., Manzini, R., Bluemel, S., Scharl, M., Rogler, G., De Pauw, E., COIMBRA MARQUES, C., Colard, A., ... Meuwis, M.-A. (01 February 2021). Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis. Journal of Crohn's and Colitis, 15 (2), 287-297. doi:10.1093/ecco-jcc/jjaa168 Peer reviewed |
 | Monin, L., Dubois, S., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., VAN DAELE, D., VIEUJEAN, S., SEIDEL, L., & Louis, E. (2021). Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort. Digestive and Liver Disease. doi:10.1016/j.dld.2020.10.040 Peer reviewed |
 | Pierre, N., Salée, C., Vieujean, S., Bequet, E., Merli, A.-M., Siegmund, B., Meuwis, M.-A., & Louis, E. (2021). Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology. Alimentary Pharmacology and Therapeutics, 54 (6), 779-791. doi:10.1111/apt.16536 Peer reviewed |
 | VIEUJEAN, S., Dauby, M., REMACLE, G., KRIDELKA, F., DEWANDRE, P.-Y., & CAPELLE, X. (2021). Rupture spontanée d’un anévrysme de l’artère splénique au cours du troisième trimestre de la grossesse. Revue Médicale de Liège. Peer reviewed |
| VIEUJEAN, S., COIBION, C., SEIDEL, L., LOUIS, E., & MEUNIER, P. (2020). Magnetic resonance enterography perfusion parameters reveal complex changes in affected and unaffected segments in Crohn's disease. Scandinavian Journal of Gastroenterology. doi:10.1080/00365521.2020.1802773 Peer Reviewed verified by ORBi |
Cremer, A., Lobaton, T., VIEUJEAN, S., Bossuyt, P., Rahier, J.-F., Baert, F., Dewit, O., Macken, E., Somers, M., Vijverman, A., Deflandre, J., Van Hootegem, P., Mana, F., Willandt, B., Caenepeel, P., Humblet, E., D'Heygere, F., Verreth, A., El Nawar, A., ... Franchimont, D. (May 2020). Tofacitinib induces clinical and endoscopic remission in biologic refractory Ulcerative Colitis patients: A real-world Belgian cohort study [Poster presentation]. Digestive Disease Week (DDW), Chicago, United States. Peer reviewed |
Cremer, A., Lobaton, T., VIEUJEAN, S., Bossuyt, P., Rahier, J.-F., Baert, F., Dewit, O., Macken, E., Somers, M., Vijverman, A., Deflandre, J., Van Hootegem, P., Mana, F., Willandt, B., Caenepeel, P., Humblet, E., D'Heygere, F., Verreth, A., El Nawar, A., ... Franchimont, D. (05 March 2020). Tofacitinib induces clinical and endoscopic remission in biologic refractory Ulcerative Colitis patients: A real-world Belgian cohort study [Paper presentation]. Belgian Week of Gastroenterology, Antwerp, Belgium. Peer reviewed |
Vieujean, S., Hu, S., Bequet, E., Salee, C., Massot, C., BLETARD, N., Pierre, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., Delvenne, P., Louis, E., & Meuwis, M.-A. (05 March 2020). Increased Endoplasmic Reticulum stress specific chaperones characterise CD fibrosis epithelium tissues and participates to in vitro induction of intestinal fibroblasts differentiation [Poster presentation]. Belgian Week of Gastroenterology, Antwerpen, Belgium. Peer reviewed |
Merli, A.-M., Vieujean, S., MASSOT, C., BLETARD, N., QUESADA CALVO, F., Baiwir, D., Mazzucchelli, G., Servais, L., WERA, O., Oury, C., de Leval, L., Sempoux, C., Manzini, R., Scharl, M., Rogler, G., De Pauw, E., COIMBRA MARQUES, C., COLARD, A., Vijverman, A., ... LOUIS, E. (04 March 2020). SLC12A2 as a potential histological marker of ulcerative colitis associated colorectal dysplasia [Paper presentation]. Belgian Week of Gastroenterologyw, Antwerp, Belgium. Peer reviewed |
Cremer, A., Lobaton, T., VIEUJEAN, S., Bossuyt, P., Rahier, J.-F., Baert, F., Dewit, O., Macken, E., Somers, M., Vijverman, A., Deflandre, J., Van Hootegem, P., Mana, F., Willandt, B., Caenepeel, P., Humblet, E., D'Heygere, F., Verreth, A., El Nawar, A., ... Franchimont, D. (14 February 2020). Tofacitinib induces clinical and endoscopic remission in biologic refractory Ulcerative Colitis patients: A real-world Belgian cohort study [Poster presentation]. European Crohn's and Colitis Organisation (ECCO), Vienna, Austria. Peer reviewed |
Vieujean, S., Hu, S., Bequet, E., Salee, C., Massot, C., BLETARD, N., Pierre, N., Quesada Calvo, F., Baiwir, D., Mazzucchelli, G., De Pauw, E., Delvenne, P., LOUIS, E., & Meuwis, M.-A. (14 February 2020). Increased Endoplasmic Reticulum stress specific chaperones characterise CD fibrosis epithelium tissues and participate to in vitro induction of intestinal fibroblasts differentiation [Poster presentation]. European Crohn's and Colitis Organisation (ECCO), Vienna, Austria. Peer reviewed |
 | VIEUJEAN, S., MOENS, A., ROTHFUSS, K., SAVARINO, E., VAVRICKA, S., REENAERS, C., FERRANTE, M., & RAHIER, J.-F. (February 2019). Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulator(s) [Poster presentation]. 14th Congress of ECCO. Peer reviewed |
VIEUJEAN, S., BURY, T., GASPARD, L., GIOT, J.-B., MAWEJA, S., LOUIS, E., & VAN KEMSEKE, C. (February 2019). Ganglionic tuberculosis in a Crohn’s disease patient treated by infliximab despite anti-tuberculosis chemoprophylaxis [Paper presentation]. Belgian Week of Gastroenterology 31st Edition - BWGE 2019. Peer reviewed |
 | VIEUJEAN, S., MOENS, A., ROTHFUSS, K., SAVARINO, E., VAVRICKA, S., REENAERS, C., FERRANTE, M., & RAHIER, J.-F. (February 2019). Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulators [Poster presentation]. Belgian Week of Gastroenterology - 31th edition. Peer reviewed |
 | VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Immunosuppressive co-treatment with Infliximab and adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time [Poster presentation]. 30th edition of Belgian Week of Gastroenterology. Peer reviewed |
 | VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Étude dans la vie réelle de l’association d’un traitement immunosuppresseur avec l’Infliximab et l’Adalimumab dans la colite ulcéreuse [Poster presentation]. Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive. |
 | VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis [Poster presentation]. 13th Congress of ECCO, Vienna, Austria. Peer reviewed |
| VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., LOUIS, E., & VAN KEMSEKE, C. (February 2018). Curious intra-rectal “laterally spreading tumor” in immunosuppressed patient with ulcerative colitis [Paper presentation]. Belgian Week of Gastroenterology 30th Edition - BWGE 2018. Peer reviewed |
 | VIEUJEAN, S., LOUIS, E., & REENAERS, C. (October 2017). Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis [Poster presentation]. 25th UEG week, Barcelona, Spain. Peer reviewed |
 | VIEUJEAN, S., BRASSEUR, E., GHUYSEN, A., & D'ORIO, V. (17 January 2015). PROBLEMATIQUE DES LITS D’AVAL POUR LES ADMISSIONS VIA LES URGENCES [Poster presentation]. SYMPOSIUM OF THE BELGIAN SOCIETY OF EMERGENCY AND DISASTER MEDECINE, Bruxelles, Belgium. Peer reviewed |
